BURLINGTON, Mass., Dec. 10, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that Neil Bodick, M.D., Ph.D., Chief Scientific Officer, will retire effective January 3, 2020. Dr. Bodick co-founded Flexion in 2007 with Michael Clayman, M.D., the company`s President and Chief Executive Officer. `Simply put, Neil is a unique talent whose extraordinary impact at Flexion has shaped who we`ve become as a company,` said Dr. Clayman. `His unparalleled intellect, scientific acumen and creativity coupled with an extraordinary commitment to win make him a singularly effective physician-scientist and executive. For me personally, this is bittersweet news as I have deep...
|